 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

AngioDynamics, Inc. (NASDAQ:ANGO  Free Report)  Equities research analysts at HC Wainwright issued their Q1 2024 EPS estimates for shares of AngioDynamics in a report released on...

Brokers Issue Forecasts for AngioDynamics, Inc.'s Q1 2024 Earnings (NASDAQ:ANGO)

AngioDynamics (NASDAQ:ANGO  Get Free Report) and Femasys (NASDAQ:FEMY  Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two...

Head to Head Comparison: AngioDynamics (NASDAQ:ANGO) vs. Femasys (NASDAQ:FEMY)

AngioDynamics, Inc. (NASDAQ:ANGO  Get Free Report) was the recipient of a large growth in short interest in the month of August. As of August 31st, there was short interest totalling 1,220,000...

AngioDynamics, Inc. (NASDAQ:ANGO) Short Interest Update

Investors considering a purchase of AngioDynamics Inc (ANGO) stock, but cautious about paying the going market price of 7.20/share, might benefit from considering selling puts among the...

Commit To Buy AngioDynamics At $5, Earn 6.7% Annualized Using Options

ANGO's total volume now sits at 795.9K. The +-0.21% average daily price change was insignificant these 4 days, leaving ANGO's price at $7.22...

The volume for AngioDynamics stock increased for four consecutive days, resulting in a record-breaking daily growth of 93% of the 65-Day Volume Moving Average

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the bodys vascular system, expanding cancer treatment options...

AngioDynamics to Report Fiscal 2024 First Quarter Financial Results on October 4, 2023

Principal Financial Group Inc. lowered its holdings in AngioDynamics, Inc. (NASDAQ:ANGO  Free Report) by 1.2% in the 1st quarter, according to the company in its most recent filing with the...

Principal Financial Group Inc. Reduces Stake in AngioDynamics, Inc. (NASDAQ:ANGO)

Russell Investments Group Ltd. purchased a new stake in shares of AngioDynamics, Inc. (NASDAQ:ANGO  Free Report) in the first quarter, according to its most recent 13F filing with the...

Russell Investments Group Ltd. Purchases Shares of 28,398 AngioDynamics, Inc. (NASDAQ:ANGO)

AngioDynamics, Inc. (NASDAQ:ANGO  Free Report)  Stock analysts at Zacks Research dropped their Q2 2024 earnings estimates for AngioDynamics in a note issued to investors on Tuesday...

Zacks Research Analysts Cut Earnings Estimates for AngioDynamics, Inc. (NASDAQ:ANGO)

StockNews.com initiated coverage on shares of AngioDynamics (NASDAQ:ANGO Free Report) in a report released on Thursday morning. The brokerage issued a hold rating on the medical instruments suppliers stock. Separately, Canaccord Genuity Group raised their target price on shares of AngioDynamics from...

AngioDynamics (NASDAQ:ANGO) Coverage Initiated by Analysts at StockNews.com

AngioDynamics, Inc. operates as a medical device company, which engages in the development, manufacturing and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. It operates through the Med Tech and Med Device segments. It offers ablation systems, fluid management systems, vascular access, angiographic, drainage, thrombolytic, and venous products. The company was founded by Howard S. Stern and Eamonn P. Hobbs on February 9, 1988 and is headquartered in Latham, NY.

Watchers	718
52-Wk Low	$6.72
52-Wk High	$21.88

Market Cap	$287.22M
Volume (M)	353,221.00
52-Wk High	$21.88
52-Wk Low	$6.72

ANGO Angiodynamic Inc

About

Feed

News

Sentiment

Earnings

Fundamentals